跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEG-interleukin-2
首页
药物
PEG-interleukin-2
Investigational
Biotech
PEG-interleukin-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
HUMAN INTERLEUKIN 2-POLYETHYLENE GLYCOL CONJUGATE AND USE THEREOF
申请人: NOVOCODEX BIOPHARMACEUTICALS CO LTD
优先权: 2021
CN
EP
US
WO
4 件公开
HUMAN INTERLEUKIN 2-POLYETHYLENE GLYCOL CONJUGATE AND USE THEREOF
申请人: NOVOCODEX BIOPHARMACEUTICALS CO LTD
优先权: 2021
US
Glucocorticoid combined with polyethylene glycol-modified interleukin 2 for treating respiratory disease
申请人: XIE YANHUI
优先权: 2016
US
MODIFIED IL-2 PROTEINS, PEG CONJUGATES, AND USES THEREOF
申请人: CSPC MEGALITH BIOPHARMACEUTICAL CO LTD
优先权: 2019
US
WO
3 件公开
Fixed-point modified biased activated interleukin-2 and application thereof
申请人: UNIV BEIJING
优先权: 2024
CN
Macrimmune V, a composition for treating cancer
申请人: LIPTON JAMES S
优先权: 2001
US
Pegylated recombinant human interleukin-11 (rhIL-11) mutant as well as preparation method and application thereof
申请人: UNIV XUZHOU MEDICAL
优先权: 2024
CN
TREATMENT OF ATOPIC DERMATITIS WITH POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN 2, GLUCOCORTICOID AND HYALURONIC ACID
申请人: XIE YANHUI
优先权: 2023
CN
EP
US
WO
4 件公开
药物
反馈